Consistent with this, we found all angiogenesis-related genes to be significantly upregulated in non-pCR patients, with VEGFA, CXCL8, CXCL2, CXCL3, and HBEGF identified as core drivers of tumor angiogenesis and immune escape. This evidence concerns the gene CXCL3 and neoplasm.